Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression
NC Salloum, M Fava, MP Freeman… - Depression and …, 2019 - Wiley Online Library
Objective To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment‐resistant depression (TRD). Methods In a multisite …
midazolam (active placebo) in treatment‐resistant depression (TRD). Methods In a multisite …
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.
NC Salloum, M Fava, MP Freeman, M Flynn… - Depression and …, 2018 - europepmc.org
Objective To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment-resistant depression (TRD). Methods In a multisite …
midazolam (active placebo) in treatment-resistant depression (TRD). Methods In a multisite …
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
NC Salloum, M Fava, MP Freeman, M Flynn… - 2019 - pubmed.ncbi.nlm.nih.gov
Objective To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment-resistant depression (TRD). Methods In a multisite …
midazolam (active placebo) in treatment-resistant depression (TRD). Methods In a multisite …
[PDF][PDF] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
NC Salloum, M Fava, MP Freeman, M Flynn… - mgh-ctni.org
Objective: To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
NC Salloum, M Fava… - Depression …, 2019 - utsouthwestern.elsevierpure.com
Objective: To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …
[PDF][PDF] Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression
NC Salloum, M Fava, MP Freeman, M Flynn… - mgh-ctni.org
Objective: To examine the effect of high baseline anxiety on response to ketamine versus
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …
midazolam (active placebo) in treatment-resistant depression (TRD). Methods: In a multisite …